Ultrasound reverses chemo-resistance in breast cancer stem cell-like cells by altering ABCG2 expression.
In conclusion, this new US-MB treatment condition has clinical potential in breast cancer therapy by targeting BCSCs; thereby holding benefits for breast cancer patients.
PMID: 28935760 [PubMed - as supplied by publisher]
Source: Bioscience Reports - Category: Biomedical Science Authors: Guo L, Zheng P, Fan H, Wang H, Xu W, Zhou W Tags: Biosci Rep Source Type: research
More News: Biomedical Science | Breast Cancer | Cancer | Cancer & Oncology | Cancer Therapy | Chemotherapy | Stem Cell Therapy | Stem Cells | Ultrasound